Posted inGenetics
Profluent’s AI-Designed Gene Editor Provides Glimpse Into Generalizable Platform
Illustration of OpenCRISPR-1 [Profluent] Ali Madani, PhD, CEO of Profluent, says there’s an urgent need to move away from the…
Posted inGenetics
Early Gene Therapy Provides Lasting HIV Protection in Newborn Primates
Despite decades of progress, pediatric HIV continues to pose devastating challenges in regions with limited access to care. Globally, more…
Posted inBiotechnology
Cutting-Edge Neuromodulation Advances in Parkinson’s Disease
In recent years, the landscape of Parkinson’s disease (PD) treatment has undergone a remarkable transformation, particularly in the realm of…
Posted inBiotechnology
Processing Environments Shape Food-Related Antibiotic Resistome
In recent years, the global scientific community has witnessed an intensifying focus on antibiotic resistance, particularly how it manifests in…
Posted inMedical Technology
Cardiosense scores FDA clearance for wearable sensor that monitors heart function
Medical AI company Cardiosense has claimed FDA clearance for its CardioTag device, a wearable sensor that provides a noninvasive approach…
Posted inResearch
Backed by Big Pharma, NIH foundation launches program to push animal testing alternatives across regulatory finish line
As the fervor around ending animal testing in drug development has grown since President Donald Trump started his second term,…
Posted inGenetics
Decision Making AI “Scientists” Perform Sophisticated, Interdisciplinary Research
Imagine you’re a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you…
Posted inGenetics
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a Netherlands-based CDMO, acquired Meribel Pharma Solutions’ site in Uppsala, Sweden, to support early-phase, IP-driven drug substance development and…
Posted inBiotechnology
Multi-Proteomic Analysis Reveals Host Risks in VZV
In a groundbreaking study published in Nature Microbiology, researchers have unveiled a comprehensive multi-proteomic landscape of the varicella-zoster virus (VZV)…
Posted inMedical Technology
InBrain Neuroelectronics reports positive interim results from study of BCI tech
Barcelona-based InBrain Neuroelectronics shared interim findings from a first-in-human clinical study of its graphene-based brain-computer interface (BCI) technology. InBrain says…